Drug Type Small molecule drug |
Synonyms L-692289 |
Target |
Action inhibitors |
Mechanism 1,3-beta-glucan synthase inhibitors |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingDiscovery |
First Approval Date- |
Regulation- |
Molecular FormulaC50H80N8O15 |
InChIKeyZDGSWUBIMMFISL-IQTRWBIESA-N |
CAS Registry144539-82-2 |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Candidiasis | Discovery | United States | - | |
| Pneumocystis Infections | Discovery | United States | - |





